Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. (Q39775786)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19908287%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19908287%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

0 references

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19908287%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ana I Rojo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19908287%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

María L de Ceballos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19908287%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Nadia G Innamorato

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19908287%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ana M Martín-Moreno

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19908287%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Masayuki Yamamoto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19908287%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

1 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19908287%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19908287%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19908287%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19908287%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

588-598

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19908287%20AND%20SRC:MED&resulttype=core&format=json

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Bioenergetic and oxidative stress in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Molecular Pathways of Neurodegeneration in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Ibuprofen and apigenin induce apoptosis and cell cycle arrest in activated microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Modifications of the iron-neuromelanin system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Ibuprofen and the mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Molecular pathophysiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Exploring the full spectrum of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Oxidative damage in nucleic acids and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

The pathogenesis of cell death in Parkinson's disease--2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Polymorphism in environment responsive genes and association with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Association of a polymorphism in the ABCB1 gene with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Glutathione and Parkinson's disease: is this the elephant in the room?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

7 January 2021

Transcribe to survive: transcriptional control of antioxidant defense programs for neuroprotection in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

7 January 2021

Optimized isolation enables ex vivo analysis of microglia from various central nervous system regions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

7 January 2021

Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

7 January 2021

The transcription factor Nrf2 is a therapeutic target against brain inflammation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

7 January 2021

The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

7 January 2021

Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

7 January 2021

An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

7 January 2021

Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

7 January 2021

Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20947

7 January 2021

Identifiers

DOI

10.1002/GLIA.20947

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19908287%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference